GlobeStar Therapeutics Corporation Stock
Stocks
GSTC
US37960P1049
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
09:40:34 2025-12-18 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
+9,900.00% | +9,900.00% |
| Market Cap | 621K 532K 497K 456K 858K 59.31M 872K 5.87M 2.3M 29.75M 2.33M 2.28M 98.36M | P/E 2022 |
-1.56x | P/E 2023 | -0.76x |
|---|---|---|---|---|---|
| Enterprise Value | 987K 846K 790K 725K 1.36M 94.3M 1.39M 9.32M 3.65M 47.29M 3.7M 3.62M 156M | EV / Sales 2022 |
-
| EV / Sales 2023 | - |
| Free-Float |
93.7% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.04 |
| 10 years | 0 | | 0.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Katzaroff
CEO | Chief Executive Officer | 68 | 2021-03-02 |
David Croom
PRN | Corporate Officer/Principal | - | 2021-05-05 |
Brooke Greenwald
SAM | Sales & Marketing | - | 2021-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
James Katzaroff
CHM | Chairman | 68 | - |
William Farley
BRD | Director/Board Member | 70 | 2021-04-27 |
| Director/Board Member | - | 2021-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/23/22 | Other | Chief Financial Officer | 3,041,721 | 0.4383% | ||
| 5/12/21 | Others | Chief Executive Officer | 72,042,253 | 15.1464% | ||
| 2/10/21 | Other | CFO | 4,000,000 | 0.8577% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +9,900.00% | +9,900.00% | -96.15% | 1.24K | |
| +0.85% | +1.89% | +1.99% | +24.20% | 50.5B | |
| -0.62% | +4.58% | +487.47% | +624.71% | 46.01B | |
| +2.09% | +4.96% | +20.59% | +95.21% | 42.85B | |
| +3.85% | +3.13% | +29.60% | +16.50% | 41.03B | |
| -0.72% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +3.04% | +1.89% | +31.62% | +143.62% | 16.98B | |
| +4.33% | +1.63% | - | - | 17.05B | |
| +1.84% | +2.74% | +4.65% | +33.97% | 14.3B | |
| +3.87% | +1.98% | +82.99% | +45.80% | 13.84B | |
| Average | +1.87% | +1.81% | +1,175.20% | +103.98% | 27.46B | |
| Weighted average by Cap. | +1.63% | +2.37% | +104.65% | +154.60% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.49M -1.28M -1.19M -1.09M -2.06M -142M -2.09M -14.06M -5.51M -71.32M -5.59M -5.46M -236M | -1.95M -1.67M -1.56M -1.43M -2.69M -186M -2.74M -18.42M -7.21M -93.44M -7.32M -7.16M -309M |
| Net Debt | 152K 131K 122K 112K 211K 14.56M 214K 1.44M 564K 7.3M 572K 560K 24.14M | 366K 314K 293K 269K 506K 34.98M 514K 3.46M 1.35M 17.55M 1.37M 1.34M 58.01M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- GSTC Stock
Select your edition
All financial news and data tailored to specific country editions
